Skip to main content
. 2022 Mar;10(6):304. doi: 10.21037/atm-22-556

Figure 2.

Figure 2

m6A RNA methylation drives the downregulation of DBH-AS1 in PC. (A) GEPIA data revealed a positive correlation between DBH-AS1 and METTL3 expression levels in PC. (B) qPCR analysis of DBH-AS1 expression in PC cells treated with shMETTL3 or shControl. (C) The SRAMP database was utilized to detect m6A methylation loci within DBH-AS1. (D) MeRIP-PCR analysis of m6A-modified DBH-AS1. (E) MeRIP-PCR analysis of m6A-modified DBH-AS1 levels in cells treated with shControl or shMETTL3. (F) The impact of METTL3 on the degradation of DBH-AS1. (B,D-F) t-test. Data are means ± SEM from triplicate experiments, *, P<0.05. GEPIA, gene expression profiling interactive analysis database; PC, pancreatic cancer; qPCR, quantitative polymerase chain reaction; SRAMP, sequence-based RNA adenosine methylation site predictor; MeRIP, methylated RNA immunoprecipitation; sh, short hairpin.